{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:28:38Z","timestamp":1792700918621,"version":"4.5.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Pharm. Res."],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12272-013-0105-7","type":"journal-article","created":{"date-parts":[[2013,3,31]],"date-time":"2013-03-31T07:15:13Z","timestamp":1364714113000},"page":"651-659","source":"Crossref","is-referenced-by-count":103,"title":["Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia"],"prefix":"10.1007","volume":"36","author":[{"given":"Eun Ji","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarmila","family":"Amatya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hoon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunyoung","family":"Seol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heeyong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-Hee","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Hee","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,4,1]]},"reference":[{"key":"105_CR1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2165\/00003495-200363050-00004","volume":"63","author":"AC Altamura","year":"2003","unstructured":"Altamura, A.C., F. Sassella, A. Santini, C. Montresor, S. Fumagalli, and E. Mundo. 2003. Intramuscular preparations of antipsychotics: Uses and relevance in clinical practice. Drugs 63: 493\u2013512.","journal-title":"Drugs"},{"key":"105_CR3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.2174\/138945012799499785","volume":"13","author":"R Baweja","year":"2012","unstructured":"Baweja, R., K. Sedky, and S. Lippmann. 2012. Long-acting antipsychotic medications. Current Drug Targets 13: 555\u2013560.","journal-title":"Current Drug Targets"},{"key":"105_CR4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2147\/NDT.S8505","volume":"6","author":"D Bishara","year":"2010","unstructured":"Bishara, D. 2010. Once-monthly paliperidone injection for the treatment of schizophrenia. Neuropsychiatric Disease and Treatment 6: 561\u2013572.","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"105_CR5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0168-3659(88)90082-X","volume":"8","author":"Y Cha","year":"1988","unstructured":"Cha, Y., and C.G. Pitt. 1988. A one-week subdermal delivery system for l-methadone based on biodegradable microcapsules. Journal of Controlled Release 8: 69\u201378.","journal-title":"Journal of Controlled Release"},{"key":"105_CR6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s40005-012-0024-5","volume":"42","author":"JS Choi","year":"2012","unstructured":"Choi, J.S., K. Seo, and J.W. Yoo. 2012. Recent advances in PLGA particulate systems for drug delivery. Journal of Pharmaceutical Investigation 42: 155\u2013163.","journal-title":"Journal of Pharmaceutical Investigation"},{"key":"105_CR7","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1586\/ern.12.137","volume":"12","author":"P Chue","year":"2012","unstructured":"Chue, P., and J. Chue. 2012a. A review of paliperidone palmitate. Expert Review of Neurotherapeutics 12: 1383\u20131397.","journal-title":"Expert Review of Neurotherapeutics"},{"key":"105_CR8","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1517\/14656566.2012.686169","volume":"13","author":"P Chue","year":"2012","unstructured":"Chue, P., and J. Chue. 2012b. A review of olanzapine pamoate. Expert Opinion on Pharmacotherapy 13: 1661\u20131670.","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"105_CR9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.schres.2003.11.001","volume":"70","author":"M Eerdekens","year":"2004","unstructured":"Eerdekens, M., I. Van Hove, B. Remmerie, and E. Mannaert. 2004. Pharmacokinetics and tolerability of long-acting risperidone in schizophrenia. Schizophrenia Research 70: 91\u2013100.","journal-title":"Schizophrenia Research"},{"key":"105_CR10","first-page":"18","volume":"64","author":"L Ereshefsky","year":"2003","unstructured":"Ereshefsky, L., and C.A. Mascarenas. 2003. Comparison of the effects of different routes of antipsychotic administration on pharmacokinetics and pharmacodynamics. Journal of Clinical Psychiatry 64: 18\u201323.","journal-title":"Journal of Clinical Psychiatry"},{"key":"105_CR11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2165\/00126839-200506030-00001","volume":"6","author":"L Ereshefsky","year":"2005","unstructured":"Ereshefsky, L., and E. Mannaert. 2005. Pharmacokinetic profile and clinical efficacy of long-acting risperidone: Potential benefits of combining an atypical antipsychotic and a new delivery system. Drugs in R&D 6: 129\u2013137.","journal-title":"Drugs in R&D"},{"key":"105_CR12","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1192\/bjp.195.52.s29","volume":"52","author":"WW Fleischhacker","year":"2009","unstructured":"Fleischhacker, W.W. 2009. Second-generation antipsychotic long-acting injections: Systematic review. British Journal of Psychiatry 52: S29\u2013S36.","journal-title":"British Journal of Psychiatry"},{"key":"105_CR13","doi-asserted-by":"crossref","first-page":"396","DOI":"10.2165\/00003088-198917060-00004","volume":"17","author":"JS Froemming","year":"1989","unstructured":"Froemming, J.S., Y.W. Lam, M.W. Jann, and C.M. Davis. 1989. Pharmacokinetics of haloperidol. Clinical Pharmacokinetics 17: 396\u2013423.","journal-title":"Clinical Pharmacokinetics"},{"key":"105_CR14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2165\/00023210-200418020-00005","volume":"18","author":"TS Harrison","year":"2004","unstructured":"Harrison, T.S., and K.L. Goa. 2004. Long-acting risperidone: A review of its use in schizophrenia. CNS Drugs 18: 113\u2013132.","journal-title":"CNS Drugs"},{"key":"105_CR15","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2165\/00023210-200620050-00004","volume":"20","author":"J Horacek","year":"2006","unstructured":"Horacek, J., V. Bubenikova-Valesova, M. Kopecek, T. Palenicek, C. Dockery, P. Mohr, and C. H\u00f6schl. 2006. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs 20: 389\u2013409.","journal-title":"CNS Drugs"},{"key":"105_CR16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.colsurfb.2011.03.043","volume":"86","author":"Z Hu","year":"2011","unstructured":"Hu, Z., Y. Liu, W. Yuan, F. Wu, J. Su, and T. Jin. 2011. Effect of bases with different solubility on the release behavior of risperidone loaded PLGA microspheres. Colloids and Surfaces B: Biointerfaces 86: 206\u2013211.","journal-title":"Colloids and Surfaces B: Biointerfaces"},{"key":"105_CR17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/10401230309085668","volume":"15","author":"MM Iqbal","year":"2003","unstructured":"Iqbal, M.M., A. Rahman, Z. Husain, S.Z. Mahmud, W.G. Ryan, and J.M. Feldman. 2003. Clozapine: A clinical review of adverse effects and management. Annals of Clinical Psychiatry 15: 33\u201348.","journal-title":"Annals of Clinical Psychiatry"},{"key":"105_CR18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0022-3565(25)24408-1","volume":"244","author":"PA Janssen","year":"1988","unstructured":"Janssen, P.A., C.J. Niemegeers, F. Awouters, K.H. Schellekens, A.A. Megens, and T.F. Meert. 1988. Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties. Journal of Pharmacology and Experimental Therapeutics 244: 685\u2013693.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"105_CR19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1092852900025608","volume":"11","author":"JM Kane","year":"2006","unstructured":"Kane, J.M. 2006. Utilization of long-acting antipsychotic medication in patient care. CNS Spectrums 11: 1\u20137.","journal-title":"CNS Spectrums"},{"key":"105_CR20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ijpharm.2007.10.030","volume":"354","author":"D Klose","year":"2008","unstructured":"Klose, D., F. Siepmann, K. Elkharraz, and J. Siepmann. 2008. PLGA-based drug delivery systems: Importance of the type of drug and device geometry. International Journal of Pharmaceutics 354: 95\u2013103.","journal-title":"International Journal of Pharmaceutics"},{"key":"105_CR21","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.clinthera.2004.12.009","volume":"26","author":"ED Knox","year":"2004","unstructured":"Knox, E.D., and G.L. Stimmel. 2004. Clinical review of a long-acting, injectable formulation of risperidone. Clinical Therapeutics 26: 1994\u20132002.","journal-title":"Clinical Therapeutics"},{"key":"105_CR22","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1017\/S1461145709990988","volume":"13","author":"M Kramer","year":"2010","unstructured":"Kramer, M., R. Litman, D. Hough, R. Lane, P. Lim, Y. Liu, and M. Eerdekens. 2010. Paliperidone palmitate, a potential long-acting treatment for patients with schizophrenia. Results of a randomized, double-blind, placebo-controlled efficacy and safety study. International Journal of Neuropsychopharmacology 13: 635\u2013647.","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"105_CR23","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1176\/appi.ajp.160.7.1209","volume":"160","author":"S Leucht","year":"2003","unstructured":"Leucht, S., T.R. Barnes, W. Kissling, R.R. Engel, C. Correll, and J.M. Kane. 2003. Relapse prevention in schizophrenia with new-generation antipsychotics: A systematic review and exploratory metaanalysis of randomized, controlled trials. American Journal of Psychiatry 160: 1209\u20131222.","journal-title":"American Journal of Psychiatry"},{"key":"105_CR24","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1016\/S0140-6736(12)60239-6","volume":"379","author":"S Leucht","year":"2012","unstructured":"Leucht, S., M. Tardy, K. Komossa, S. Heres, W. Kissling, G. Salanti, and J.M. Davis. 2012. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: A systematic review and meta-analysis. Lancet 379: 2063\u20132071.","journal-title":"Lancet"},{"key":"105_CR25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0022-3565(25)13416-2","volume":"247","author":"JE Leysen","year":"1988","unstructured":"Leysen, J.E., W. Gommeren, A. Eens, D. de Chaffoy de Courcelles, J.C. Stoof, and P.A. Janssen. 1988. Biochemical profile of risperidone, a new antipsychotic. Journal of Pharmacology and Experimental Therapeutics 247: 661\u2013670.","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"105_CR26","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2147\/NDT.S3072","volume":"6","author":"JP Lindenmayer","year":"2010","unstructured":"Lindenmayer, J.P. 2010. Long-acting injectable antipsychotics: Focus on olanzapine pamoate. Journal of Neuropsychiatric Disease and Treatment 6: 261\u2013267.","journal-title":"Journal of Neuropsychiatric Disease and Treatment"},{"key":"105_CR27","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1023\/A:1012165731390","volume":"14","author":"JP Luo","year":"1997","unstructured":"Luo, J.P., J.W. Hubbard, and K.K. Midha. 1997. Studies on the mechanism of absorption of depot neuroleptics: Fluphenazine decanoate in sesame oil. Pharmaceutical Research 14: 1079\u20131084.","journal-title":"Pharmaceutical Research"},{"key":"105_CR28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-3659(86)90071-4","volume":"3","author":"HV Maulding","year":"1986","unstructured":"Maulding, H.V., T.R. Tice, D.R. Cowsar, J.W. Fong, J.E. Pearson, and J.P. Nazareno. 1986. Biodegradable microcapsules: Acceleration of polymeric excipient hydrolytic rate by incorporation of a basic medicament. Journal of Controlled Release 3: 103\u2013117.","journal-title":"Journal of Controlled Release"},{"key":"105_CR29","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1517\/14656566.2011.553193","volume":"12","author":"D Naber","year":"2011","unstructured":"Naber, D. 2011. Olanzapine pamoate for the treatment of schizophrenia. Expert Opinion on Pharmacotherapy 12: 627\u2013633.","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"105_CR30","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1185\/03007990152673864","volume":"17","author":"M Naheed","year":"2001","unstructured":"Naheed, M., and B. Green. 2001. Focus on clozapine. Current Medical Research and Opinion 17: 223\u2013229.","journal-title":"Current Medical Research and Opinion"},{"key":"105_CR31","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s12272-010-0718-z","volume":"33","author":"EJ Park","year":"2010","unstructured":"Park, E.J., T.H. Tak, D.H. Na, and K.C. Lee. 2010. Effect of PEGylation on stability of peptide in poly(lactide-co-glycolide) microspheres. Archives of Pharmacal Research 33: 1111\u20131116.","journal-title":"Archives of Pharmacal Research"},{"key":"105_CR32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ijpharm.2011.08.035","volume":"420","author":"A Rawat","year":"2011","unstructured":"Rawat, A., E. Stippler, V.P. Shah, and D.J. Burgess. 2011. Validation of USP apparatus 4 method for microsphere in vitro release testing using Risperdal Consta. International Journal of Pharmaceutics 420: 198\u2013205.","journal-title":"International Journal of Pharmaceutics"},{"key":"105_CR33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijpharm.2012.05.006","volume":"434","author":"A Rawat","year":"2012","unstructured":"Rawat, A., U. Bhardwaj, and D.J. Burgess. 2012. Comparison of in vitro\u2013in vivo release of Risperdal Consta microspheres. International Journal of Pharmaceutics 434: 115\u2013121.","journal-title":"International Journal of Pharmaceutics"},{"key":"105_CR34","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1345\/aph.1M721","volume":"46","author":"V Risbood","year":"2012","unstructured":"Risbood, V., J.R. Lee, J. Roche-Desilets, and M.A. Fuller. 2012. Lurasidone: An atypical antipsychotic for schizophrenia. Annals of Pharmacotherapy 46: 1033\u20131046.","journal-title":"Annals of Pharmacotherapy"},{"key":"105_CR35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euroneuro.2005.04.009","volume":"15","author":"W R\u00f6ssler","year":"2005","unstructured":"R\u00f6ssler, W., H.J. Salize, J. van Os, and A. Riecher-R\u00f6ssler. 2005. Size of burden of schizophrenia and psychotic disorders. European Neuropsychopharmacology 15: 399\u2013409.","journal-title":"European Neuropsychopharmacology"},{"key":"105_CR36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4062\/biomolther.2012.20.1.001","volume":"20","author":"MD Rubio","year":"2012","unstructured":"Rubio, M.D., J.B. Drummond, and J.H. Meador-Woodruff. 2012. Glutamate receptor abnormalities in schizophrenia: Implications for innovative treatments. Biomolecules & Therapeutics 20: 1\u201318.","journal-title":"Biomolecules & Therapeutics"},{"key":"105_CR37","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11316870-000000000-00000","volume":"48","author":"MN Samtani","year":"2009","unstructured":"Samtani, M.N., A. Vermeulen, and K. Stuyckens. 2009. Population pharmacokinetics of intramuscular paliperidone palmitate in patients with schizophrenia: A novel once-monthly, long-acting formulation of an atypical antipsychotic. Clinical Pharmacokinetics 48: 585\u2013600.","journal-title":"Clinical Pharmacokinetics"},{"key":"105_CR38","first-page":"48","volume":"9","author":"K Sedky","year":"2010","unstructured":"Sedky, K., R. Nazir, J.P. Lindenmayer, and S. Lippman. 2010. Paliperidone palmitate: Once monthly treatment option for schizophrenia. Current Psychiatry Online 9: 48\u201350.","journal-title":"Current Psychiatry Online"},{"key":"105_CR39","doi-asserted-by":"crossref","unstructured":"Selmin, F., P. Blasi, and P. P. Deluca. 2012. Accelerated polymer biodegradation of risperidone poly(d,l-lactide-co-glycolide) microspheres. AAPS Pharm Sci Tech 13: 1465\u20131472.","DOI":"10.1208\/s12249-012-9874-4"},{"key":"105_CR40","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.addr.2007.05.010","volume":"59","author":"AT Serajuddin","year":"2007","unstructured":"Serajuddin, A.T. 2007. Salt formation to improve drug solubility. Advanced Drug Delivery Reviews 59: 603\u2013616.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"105_CR41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0010-440X(99)90082-2","volume":"40","author":"WW Shen","year":"1999","unstructured":"Shen, W.W. 1999. A history of antipsychotic drug development. Comprehensive Psychiatry 40: 407\u2013414.","journal-title":"Comprehensive Psychiatry"},{"key":"105_CR42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","volume":"28","author":"MS Shive","year":"1997","unstructured":"Shive, M.S., and J.M. Anderson. 1997. Biodegradation and biocompatibility of PLA and PLGA microspheres. Advanced Drug Delivery Reviews 28: 5\u201324.","journal-title":"Advanced Drug Delivery Reviews"},{"key":"105_CR43","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1248\/cpb.57.1251","volume":"57","author":"Z Su","year":"2009","unstructured":"Su, Z., F. Sun, Y. Shi, C. Jiang, Q. Meng, L. Teng, and Y. Li. 2009. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(d,l-lactide-co-glycolide) microsphere. Chemical & Pharmaceutical Bulletin 57: 1251\u20131256.","journal-title":"Chemical & Pharmaceutical Bulletin"},{"key":"105_CR44","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/10837451003739297","volume":"16","author":"ZX Su","year":"2011","unstructured":"Su, Z.X., Y.N. Shi, L.S. Teng, X. Li, L.X. Wang, Q.F. Meng, L.R. Teng, and Y.X. Li. 2011. Biodegradable poly(d,l-lactide-co-glycolide) (PLGA) microspheres for sustained release of risperidone: Zero-order release formulation. Pharmaceutical Development and Technology 16: 377\u2013384.","journal-title":"Pharmaceutical Development and Technology"},{"key":"105_CR45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3109\/10401230209149099","volume":"14","author":"R Tandon","year":"2002","unstructured":"Tandon, R., and M.D. Jibson. 2002. Extrapyramidal side effects of antipsychotic treatment: Scope of problem and impact on outcome. Annals of Clinical Psychiatry 14: 123\u2013129.","journal-title":"Annals of Clinical Psychiatry"},{"key":"105_CR46","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.1192\/bjp.195.52.s13","volume":"52","author":"D Taylor","year":"2009","unstructured":"Taylor, D. 2009. Psychopharmacology and adverse effects of antipsychotic long-acting injections: A review. British Journal of Psychiatry 52: S13\u2013S19.","journal-title":"British Journal of Psychiatry"},{"key":"105_CR47","doi-asserted-by":"crossref","first-page":"545","DOI":"10.4088\/JCP.v62n07a08","volume":"62","author":"M Valenstein","year":"2001","unstructured":"Valenstein, M., L.A. Copeland, R. Owen, F.C. Blow, and S. Visnic. 2001. Adherence assessments and the use of depot antipsychotics in patients with schizophrenia. Journal of Clinical Psychiatry 62: 545\u2013551.","journal-title":"Journal of Clinical Psychiatry"},{"key":"105_CR48","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ijpharm.2008.04.042","volume":"364","author":"C Wischke","year":"2008","unstructured":"Wischke, C., and S.P. Schwendeman. 2008. Principles of encapsulating hydrophobic drugs in PLA\/PLGA microparticles. International Journal of Pharmaceutics 364: 298\u2013327.","journal-title":"International Journal of Pharmaceutics"},{"key":"105_CR49","first-page":"253","volume":"34","author":"AW Zuardi","year":"1983","unstructured":"Zuardi, A.W., A.C. Giampietro, and E.R. Grassi. 1983. Double-blind comparison between two forms of haloperidol: An oral preparation and a new depot decanoate in the maintenance of schizophrenic inpatients. Current Therapeutic Research 34: 253\u2013261.","journal-title":"Current Therapeutic Research"}],"container-title":["Archives of Pharmacal Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-013-0105-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12272-013-0105-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12272-013-0105-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:42:45Z","timestamp":1745980965000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12272-013-0105-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,1]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["105"],"URL":"https:\/\/doi.org\/10.1007\/s12272-013-0105-7","relation":{},"ISSN":["0253-6269","1976-3786"],"issn-type":[{"value":"0253-6269","type":"print"},{"value":"1976-3786","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,1]]}}}